Hematology/Oncology News

Remaining current on screening for hepatocellular carcinoma correlated with a “survival benefit” in older adults with hepatitis C virus-related cirrhosis who achieved viral cure but later developed HCC, according to researchers.

Giroctocogene fitelparvovec reduced bleeding for men with moderately severe to severe hemophilia A, according to data released by the agent’s manufacturer.

The Dermatology Association of Radiation Therapy has announced new guidelines for the treatment of nonmelanoma skin cancer, according to an association press release.

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of the SJMB12 (NCT01878617) trial.

The investigational targeted radiotherapy iopofosine I 131 improved survival for certain patients with Waldenström’s macroglobulinemia, according to the agent’s manufacturer.

Informing patients of the benefit-harm balance associated with mammography screening is beneficial and did not hinder overall screening decisions, according to results of a national probability-based U.S. survey.

An FDA mandate that requires patients who receive chimeric antigen receptor T-cell therapy to stay within a certain radius of their treatment facility for nearly a month for adverse event monitoring may be overly restrictive.

Medical mistrust continues to be a major issue in the care of patients with multiple myeloma — particularly among Black individuals according to findings published in Cancer Medicine.

A 0.1 full-time equivalent-supported core faculty program led to the most fellows and faculty reporting improvements in job satisfaction and an increased sense of involvement in the fellowship program, according to survey results.

Having been exposed to benzene during work heightened the odds for lung cancer development, according to results published in American Journal of Respiratory and Critical Care Medicine.